Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: an International Oncology Study Group (IOSG) phase II protocol
(Q33331536)
scientific article
scientific article
Language:
other details
| description | scientific article |
External Links
| (P356) |
10.1002/(SICI)1096-8652(200003)63:3<125::AID-AJH3>3.0.CO;2-S
|
| (P698) |
10679801
|